查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519492

2024-2032 年按產品、應用、最終用戶（製藥和生物技術公司、學術和政府機構、合約研究組織）和地區分類的高內涵篩選市場報告

High Content Screening Market Report by Product, Application, End-User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations ), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2023 年，全球高內容放映市場IMARC Group達到 13 億美元。全球高內涵篩選市場正在經歷顯著成長，其促進因素包括透過使用整合成像技術、增加對藥物研究的投資、在最大限度地減少時間和成本的同時對篩選方法的需求不斷增加以及自動化系統的建立，藥物發現應用的快速發展。

高內容篩選市場分析：

主要市場促進因素：高內涵篩選市場的成長主要是由藥物發現和開發需求不斷成長、高通量生產成像技術的進步以及對製藥和生物技術研究的大量投資分配所推動的。此外，對快速、高效的篩選技術的需求，有助於識別和理解活性候選藥物，也促進了市場的成長。

主要市場趨勢：市場趨勢包括使用資料分析的人工智慧和機器學習演算法的快速數位化，結合產生更多生理相關結果的 3D 細胞模型，以及針對各種細胞模型的多範式分析的開發。

地理趨勢：由於製藥和生物技術行業的快速發展、持續的研發投資、先進的醫療基礎設施（與市場主要參與者和學術研究機構的存在相關），北美在市場上佔據主導地位。

競爭格局：該行業的一些主要市場參與者包括 Becton、Dickinson and Company、Bio-Rad Laboratories Inc.、Biotek Instruments Inc.、Danaher Corporation、GE Healthcare、Merck Millipore、Perkinelmer Inc.、Tecan Group Ltd.、Thermo Fisher Scientific、橫河電機公司等。

挑戰與機會：市場面臨設備與試劑成本高、資料分析與標準複雜等挑戰。另一方面，在開發新的創新成像技術或將其應用範圍擴大到藥物發現之外，以及使學術界和工業界之間的合作研究更容易研發方面，高內容篩選市場機會是巨大的。

高內容放映市場趨勢：

對藥物發現的需求不斷增加：

該市場主要是由對快速有效的藥物發現方法日益成長的需求所推動的。例如，NIH 報告稱，預計到 2025 年，全球藥品市場將幾乎翻倍，達到 1.5 兆美元，因此迫切需要先進的篩選技術。 HCS 反過來又可以同時分析許多參數，並儘早識別潛在的候選藥物，從而縮短開發時間。因此，製藥組織被迫信任 HCS，從而擴大了研究市場規模並改善了藥物的發現過程。

成像技術的不斷進步：

公司不斷開發影像技術，有助於提供更準確、更詳細、更專業的診斷工具，創造積極的高內涵篩檢市場前景。例如，美國國家科學基金會 (NSF) 報告顯示，年成長率為 6.2%，這意味著越來越多的實驗室正在採用先進成像模式的操作，應用於細胞分析的高內涵篩選。研究人員現在可以透過超解析度顯微鏡、共焦成像和活細胞成像設備即時拍攝細胞結構和運作的高品質影像。這些技術創新使未來的高內涵篩選系統具有更好的分析精度和更詳細的結果，從而使識別細胞過程和對刺激的反應的工作更加先進和徹底。因此，採用最新成像技術的更清潔、更有效率的高內容篩選系統的供應正在增加，這推動了市場的發展。

生技研究投資不斷增加

由於世界各地對生物技術的投資不斷增加，高內容篩選市場收入正經歷顯著成長。根據生物技術創新組織 (BIO) 的數據，2020 年全球生物技術研發支出超過 2,100 億美元，顯示了在推進科學知識以及開發新治療方案方面的投資。高內涵篩選透過加速細胞功能和分子間相互作用的研究過程，在生物技術研究中佔據核心地位。生物技術公司和研究機構利用新的發現目標進行藥物開發、評估化合物的功效和毒性以及闡明疾病機制是推動高內涵篩選市場需求增加的一些因素。因此，這種趨勢將導致市場成長，並將進行高內涵篩選技術的進一步研究。

高內容篩選市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品、應用和最終用戶對市場進行了分類。

按產品分類：

儀器

細胞成像和分析系統

流式細胞儀

耗材

試劑和檢測試劑盒

微孔板

其他

軟體

服務

配件

儀器儀表佔據大部分市場佔有率

該報告根據產品提供了詳細的市場細分和分析。這包括儀器（細胞成像和分析系統以及流式細胞儀）、消耗品（試劑和檢測試劑盒、微孔板等）、軟體、服務和配件。報告稱，儀器儀表佔最大部分。

儀器透過確保精確有效的細胞分析來主導市場，從而促進藥物的發現和研究。例如，NIH 預測，到 2025 年，全球研究設備和儀器的採購額將超過 530 億美元。 因此，這種高額投資導致高內容生物醫學研究對最新技術設備的需求不斷成長。然而，主要的製藥和生物技術公司已經引入了篩選平台技術，加速了藥物發現過程，這將導致高內涵篩選儀器的巨大成長。因此，從事儀器製造的人們正在將注意力轉向創造更現代化的工具，以提供更好的成像、自動化和資料分析功能，以滿足不斷尋找新事物的科學家的需求。

按應用分類：

目標識別和驗證

初級篩選和二級篩選

毒性研究

化合物分析

其他

初篩、二次篩選行業佔有率最大

報告還提供了基於應用程式的詳細市場細分和分析。這包括目標識別和驗證、初級篩選和二級篩選、毒性研究、化合物分析等。報告稱，初級篩選和二級篩選佔了最大的市場佔有率。

由於加速藥物發現過程的緊迫性日益增加，初級篩選和二級篩選在市場上佔據主導地位。根據 NIH 的資料，全球製藥業正在經歷加速成長，預計 2024 年銷售額將達到 1.2 兆美元。化合物庫很快就變得自動化和系統化。隨後，基於細胞的檢測對於在二級篩選步驟中追蹤命中化合物、表徵其功效、安全性和作用機制是必不可少的。這加速了初級和二級高內容篩選解決方案的採用。

按最終用戶分類：

製藥和生物技術公司

學術和政府機構

合約研究組織 (CRO)

製藥和生物技術公司代表了領先的細分市場

該報告根據最終用戶對市場進行了詳細的細分和分析。這包括製藥和生物技術公司、學術和政府機構以及合約研究組織 (CRO)。報告稱，製藥和生技公司佔最大部分。

製藥和生物技術公司的驅動力是加快市場領域藥物發現或開發的基本需求。根據美國國立衛生研究院 (NIH) 的數據，到 2025 年，全球藥品產業預計將超過 1.5 兆美元。此外，高內涵篩選使藥物和生物技術公司能夠進行深入的細胞測定，從而能夠評估候選藥物的有效性和副作用。透過使用高內涵篩選方法，這些公司基本上可以實現其研究工作流程的自動化，從而縮短開發時間，從而更快地將新療法推向市場。此外，影像技術和資料分析演算法的進步增強了高內涵篩檢平台發現未知生命行為和疾病機制的能力。因此，製藥和生技公司在高內涵篩選開發方面的投資很高，從而帶來了創新和病患治療結果的改善。

按地區分類：

北美洲

美國

加拿大

亞太地區

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據最大的高內容放映市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是高內容放映的最大區域市場。

由於政府向生物醫藥產業提供大量補助，北美在市場上佔據主導地位。例如，美國國立衛生研究院 (NIH) 報告稱，美國政府每年的生物醫學研究預算高達 300 億美元。然而，這項巨額投資刺激了創新，從而加強了更先進篩選技術的使用，從而促進了市場的發展。此外，該地區擁有完善的醫療基礎設施、領先的研究機構群和高水準的勞動力，這些都為該地區在高內涵篩檢市場上贏得了額外的聲譽。因此，北美在製藥和生物領域的研發設備方面始終處於領先地位。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。高內涵篩檢產業的一些主要市場參與者包括 Becton、Dickinson and Company、Bio-Rad Laboratories Inc.、Biotek Instruments Inc.、Danaher Corporation、GE Healthcare、Merck Millipore、Perkinelmer Inc.、Tecan Group Ltd.、Thermo費希爾科學公司和橫河電機公司。

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

高內涵篩選市場企業正在投資產品的研發（R&D），以升級產品、拓寬市場。 Thermo Fisher Scientific、PerkinElmer 和 GE Healthcare 等引領了高內涵篩檢影像技術的趨勢。例如，賽默飛世爾科技 (Thermo Fisher Scientific) 2020 年在研發活動上花費了約 11 億美元。這些投資旨在開發新的成像技術、自動化解決方案和軟體平台，這些技術、自動化解決方案和軟體平台能夠推動不斷成長的市場並滿足對高級細胞分析和藥物發現相關應用不斷尋求的需求。這些企業正在開發具有增強成像、自動化功能和資料分析演算法的顯微鏡系統，以滿足製藥和生物技術科學家在藥物開發和細胞分析實驗中的新興需求。

高內涵篩選最新進展：

2022 年 9 月，BD（Becton、Dickinson and Company）宣布推出名為 BD Research Cloud 的基於雲端的軟體解決方案，旨在實現流式細胞儀工作流程的自動化。該計畫的座右銘是協助免疫學、病毒學、腫瘤學和傳染病控制等不同領域的科學家。雖然 BD 研究雲的模組化和靈活方法透過縮短了解科學研究最需要的方面的時間來提高實驗品質和上市時間，但 BD 研究雲致力於增強這些領域的科學研究和創新。

2022年4月，Sysmex Europe推出了具有CE-IVD標誌的流式細胞儀XF-1600，以滿足臨床流式細胞儀實驗室的需求。該系統提供強大而可靠的免疫表現型分析能力，有助於精確表徵細胞以用於診斷和研究目的。憑藉其先進的功能和監管批准，流式細胞儀 XF-1600 提高了臨床實驗室工作流程的效率和準確性，有助於改善患者護理和結果。

本報告回答的關鍵問題：

  • 迄今為止，全球高內容放映市場的表現如何，未來幾年將如何表現？
  • 全球高內容放映市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球高內容放映市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的高內容放映市場？
  • 基於產品的市場區隔是什麼？
  • 高內容放映市場中最具吸引力的產品是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 高內容放映市場哪項應用程式最具吸引力？
  • 基於最終用戶的市場區隔是什麼？
  • 高內容放映市場中哪一個對最終用戶最具吸引力？
  • 市場競爭結構如何？
  • 全球高內容放映市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 迄今為止，全球高內容放映市場的表現如何，未來幾年將如何表現？
  • 全球高內容放映市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球高內容放映市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的高內容放映市場？
  • 基於產品的市場區隔是什麼？
  • 高內容放映市場中最具吸引力的產品是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 高內容放映市場哪項應用程式最具吸引力？
  • 基於最終用戶的市場區隔是什麼？
  • 高內容放映市場中哪一個對最終用戶最具吸引力？
  • 市場競爭結構如何？
  • 全球高內容放映市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球高內容放映市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 儀器
    • 市場走向
    • 主要類型
      • 細胞成像和分析系統
      • 流式細胞儀
    • 市場預測
  • 耗材
    • 市場走向
    • 主要類型
      • 試劑和檢測試劑盒
      • 微孔板
      • 其他
    • 市場預測
  • 軟體
    • 市場走向
    • 市場預測
  • 服務
    • 市場走向
    • 市場預測
  • 配件
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 目標識別和驗證
    • 市場走向
    • 市場預測
  • 初級篩選和二級篩選
    • 市場走向
    • 市場預測
  • 毒性研究
    • 市場走向
    • 市場預測
  • 化合物分析
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 學術和政府機構
    • 市場走向
    • 市場預測
  • 合約研究組織 (CRO)
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格指標

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Biotek Instruments Inc.
    • Danaher Corporation
    • GE Healthcare
    • Merck Millipore
    • Perkinelmer Inc.
    • Tecan Group Ltd.
    • Thermo Fisher Scientific
    • Yokogawa Electric Corporation
Product Code: SR112024A1988

The global high content screening market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032. The global high content screening market is experiencing significant growth driven by rapid advancements in drug discovery applications through the use of integrated imaging technologies, heightening investments in pharmaceutical research, escalating demand for a screening method while minimizing time and cost, and the establishment of automated system in laboratories.

High Content Screening Market Analysis:

Major Market Drivers: The high content screening market growth is driven largely by the growing demand from drug discovery and development, progress in imaging technologies featuring high-throughput production, and large investments allocation to pharmaceuticals and biotechnology studies. Besides, the demand for expeditious and productive screening techniques, aiding the identification and understanding of active drug candidates, also adds fuel to the market growth.

Key Market Trends: The market trends include the rapid digitization of AI and machine learning algorithms that use data analysis, incorporating 3D cell models that produce more physiologically relevant results, and the development of multiparadigm assays for various cellular models.

Geographical Trends: North America dominate the market due to rapid development in the pharmaceutical and biotechnology industries, ongoing investments in research and development, advanced healthcare infrastructure which connects to the presence of market key players and academic research institutions.

Competitive Landscape: Some of the major market players in the industry include Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biotek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Perkinelmer Inc., Tecan Group Ltd., Thermo Fisher Scientific, Yokogawa Electric Corporation, among many others.

Challenges and Opportunities: The market faces challenges such as the high cost of equipment and reagents, the complexity of data analysis and standards. On the other hand, high content screening market opportunities are enormous in terms of developing new innovative imaging technologies or broadening their range of applications beyond drug discovery and making collaborative studies between academia and industry easier for research and development.

High Content Screening Market Trends:

Increasing Demand for Drug Discovery:

The market is primarily driven by the increasing need for fast and effective drug discovery approaches. For instance, NIH reports that the global pharmaceutical market is anticipated to almost double and stand at 1.5 trillion dollars in 2025 thus urging for advanced screening technologies. HCS in turn enables the analyses of many parameters at the same time and the earlier identification of potential drug candidates, hence allowing shorter time to develop them. As a result, pharmaceutical organizations are forced to put their trust in HCSs which consequently makes the research market size larger and improves the discovery process of drugs.

Ongoing Advancements in Imaging Technologies:

The imaging technologies are continuously developed by companies, that help to provide more accurate, detailed, and specialized diagnostic tools, creating a positive high content screening market outlook. For instance, the National Science Foundation (NSF) report shows the annual growth of 6.2%, which means more and more laboratories are adopting the operatories of advanced imaging modalities for application in high content screening of cellular analysis. Researchers can now make high-quality images of the structures and workings of cells in real time via super-resolution microscopy, confocal imaging, and live-cell imaging facilities. Such technical innovations upgrade the high content screening systems with better analytical precision and more detailed results in the future, thus the work of identifying cellular processes and response to stimuli becomes more advanced and thorough. Hence, the supply of cleaner and more efficient high content screening systems, incorporating the latest imaging technics is rising which is responsible for the market development.

Rising Investments in Biotechnology Research

The high content screening market revenue is experiencing significant growth due to rising investments in biotechnology around the world. As per Biotechnology Innovation Organization (BIO), global spending on biotechnological R&D exceeded $210 billion in 2020 showing the investments made in advancing scientific knowledge as well as development of new therapeutic options. High content screening takes a central position in biotechnology research by speeding up the investigating process of wondering what the cells do and the interactions among the molecules. Biotech firms and research institutions utilizing new discovery targets for drug development, as well as assessing compound efficacy and toxicity, and elucidating disease mechanisms are some of the factors driving an increased high content screening market demand. As a result, this tendency will lead to market growth and further research on high content screening techniques will be done.

High Content Screening Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and end-user.

Breakup by Product:

Instruments

Cell Imaging and Analysis Systems

Flow Cytometers

Consumables

Reagents & Assay Kits

Microplates

Others

Software

Services

Accessories

Instruments accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes instruments (cell imaging and analysis systems and flow cytometers), consumables (reagents & assay kits, microplates, and others), software, services, and accessories. According to the report, instruments represented the largest segment.

Instruments dominate the market by assuring a precise and effective cellular analysis that leads to discovery of drugs and research. For instance, NIH projections forecast that the figures for worldwide purchases of the research equipment and instrumentation will pass $53 billion mark by 2025. This high magnitude investment thus accounts to the increasing demand for up-to-date technology equipment in biomedical research with high content screening instruments. However, major pharmaceutical and biotechnology firms have introduced screening platforms technologies in which drug discovery processes are accelerated that will lead to huge growth of high content screening instruments. As a result, those engaged in the manufacture of instruments are shifting their attention towards creating more modern tools that offer better imaging, automation, and data analysis features to satisfy the demand of scientists who are always looking for something new.

Breakup by Application:

Target Identification and Validation

Primary Screening and Secondary Screening

Toxicity Studies

Compound Profiling

Others

Primary screening and secondary screening hold the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes target identification and validation, primary screening and secondary screening, toxicity studies, compound profiling, and others. According to the report, primary screening and secondary screening accounted for the largest market share.

Primary screening and secondary screening dominate the market due to the rising urgency of accelerating the drug discovery process. According to data from NIH, the global pharmaceutical industry is experiencing an accelerated growth and is expected to reach an estimate of $1,200 billion in sales in 2024. This is a leverage to invest in high content screening technologies for primary screening, as the ability to evaluate large amounts of compound libraries to identify potential drug candidates quickly becomes automated and systematic. Afterward, cell-based assays are indispensable for following up on hit compounds in the secondary screening step, characterizing their efficacy, safety, and mechanism of action. This accelerates primary and secondary high content screening solutions adoption.

Breakup by End-User:

Pharmaceutical and Biotechnology Companies

Academic and Government Institutes

Contract Research Organizations (CROs)

Pharmaceutical and biotechnology companies represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CROs). According to the report, pharmaceutical and biotechnology companies represented the largest segment.

Pharmaceutical and biotechnology firms are driven by the basic necessity to speed up drug discovery or development in the field of market. As per the National Institutes of Health (NIH), the global drugs industry is anticipated to go beyond 1.5 trillion dollars by the year 2025. This abundant market chance therefore entices firms to invest in the state-of-the-art screening technologies to screen drug candidates swiftly. Moreover, high-content screening allows drug and biotechnology companies to perform in-depth cellular assays, thus enabling the evaluation of drug candidates' effectiveness and side-effect profiles. With the use of high content screening methods, these companies can essentially automate their research workflow and therefore shorten development timelines to bring novel treatments to the market faster. Furthermore, progress in imaging technology and data analysis algorithms adds to the power of high content screening platforms to the discovery of unsuspected life behaviors and disease mechanisms. Thus, investments of pharmaceutical and biotechnology companies in the development of high content screening run high leading to innovation and improvement of patient outcome.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest high content screening market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for high content screening.

North America dominates the market due to the provision of massive government grant to biomedical industry. For instance, the National Institutes of Health or NIH reported that the US government covers up to $30 billion in its yearly budget for biomedical research. This sizeable incurred investment, however, stimulates innovation, therefore enhancing the use of more advanced screening technologies resulting in the market development. Further, the area enjoys well-established medicine infrastructure, a cluster of leading research institutes and a labor force with a high level of competence which provide additional prestige to the region in the high content screening market. As result North America stays at the forefront of the equipment used in the pharmaceutical and biological sectors' research and development.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the high content screening industry include Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biotek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Perkinelmer Inc., Tecan Group Ltd., Thermo Fisher Scientific and Yokogawa Electric Corporation.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The high content screening market companies are investing in the research and development (R&D) of the product to upgrade the product and broaden the market. Thermo Fisher Scientific, PerkinElmer, and GE Healthcare, amongst others, leading the trend in imaging technologies for high-content screening. For instance, Thermo Fisher Scientific spent around 1.1 billion dollars in 2020 on R&D activities. These investments aim to develop new imaging technologies, automation solutions and software platforms that are capable of driving the growing market and meeting the ever-searching demand for advanced cellular analysis and drug discovery related applications. These businesses are developing microscopy systems with enhanced imaging, automation features, and data analysis algorithms that suit the emerging needs of pharmaceutical and biotechnology scientists in drug development and cellular analysis experiments.

High Content Screening Recent Developments:

In September 2022, BD (Becton, Dickinson and Company) announced the launch of a cloud-based software solution called BD Research Cloud intended to automate the flow cytometry workflow. The motto of the project is to assisting scientists in diverse fields, such as immunology, virology, oncology, and infectious diseases control. While the modular and flexible approach of the BD Research Cloud improves both the quality of the experiments and the time-to-market by fastening the time to insight most needed aspects of scientific investigations BD Research Cloud strives to augment scientific research and innovation in these areas.

In April 2022, Sysmex Europe launched the CE-IVD-marked Flow Cytometer XF-1600, catering to clinical flow cytometry laboratories. This system offers robust and reliable immunophenotyping capabilities, aiding in the precise characterization of cells for diagnostic and research purposes. With its advanced features and regulatory approval, the Flow Cytometer XF-1600 enhances efficiency and accuracy in clinical laboratory workflows, contributing to improved patient care and outcomes.

Key Questions Answered in This Report:

  • How has the global high content screening market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global high content screening market?
  • What is the impact of each driver, restraint, and opportunity on the global high content screening market?
  • What are the key regional markets?
  • Which countries represent the most attractive high content screening market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the high content screening market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the high content screening market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the high content screening market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global high content screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global High Content Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Cell Imaging and Analysis Systems
      • 6.1.2.2 Flow Cytometers
    • 6.1.3 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Reagents & Assay Kits
      • 6.2.2.2 Microplates
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Accessories
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Target Identification and Validation
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Primary Screening and Secondary Screening
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Toxicity Studies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Compound Profiling
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic and Government Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations (CROs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Becton, Dickinson and Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-Rad Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biotek Instruments Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 GE Healthcare
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck Millipore
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Perkinelmer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Tecan Group Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Thermo Fisher Scientific
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Yokogawa Electric Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: High Content Screening Market: Major Drivers and Challenges
  • Figure 2: Global: High Content Screening Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: High Content Screening Market: Breakup by Product (in %), 2023
  • Figure 4: Global: High Content Screening Market: Breakup by Application (in %), 2023
  • Figure 5: Global: High Content Screening Market: Breakup by End-User (in %), 2023
  • Figure 6: Global: High Content Screening Market: Breakup by Region (in %), 2023
  • Figure 7: Global: High Content Screening Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: High Content Screening (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: High Content Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: High Content Screening (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: High Content Screening (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: High Content Screening (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: High Content Screening (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: High Content Screening (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: High Content Screening (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: High Content Screening (Accessories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: High Content Screening (Accessories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: High Content Screening (Target Identification and Validation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: High Content Screening (Target Identification and Validation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: High Content Screening (Primary Screening and Secondary Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: High Content Screening (Primary Screening and Secondary Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: High Content Screening (Toxicity Studies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: High Content Screening (Toxicity Studies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: High Content Screening (Compound Profiling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: High Content Screening (Compound Profiling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: High Content Screening (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: High Content Screening (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: High Content Screening (Academic and Government Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: High Content Screening (Academic and Government Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: High Content Screening (Contract Research Organizations-CROs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: High Content Screening (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia Pacific: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia Pacific: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: High Content Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: High Content Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: High Content Screening Industry: SWOT Analysis
  • Figure 83: Global: High Content Screening Industry: Value Chain Analysis
  • Figure 84: Global: High Content Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: High Content Screening Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: High Content Screening Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: High Content Screening Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: High Content Screening Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 5: Global: High Content Screening Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: High Content Screening Market: Competitive Structure
  • Table 7: Global: High Content Screening Market: Key Players